Experimental Hematology and Oncology
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Hematology
Q1
└
Oncology
Q1
Publisher
SJR 2025
4.126
Q1
SJR Score
H-Index
58
Citations / Doc (2yr)
10.49
Total Docs. (latest)
138
Total Citations (3yr)
3,240
Publication type
Journals
ISSN
21623619
Coverage
2012-2026
Journal Rank
#413
Subject Categories
Cancer Research
Q1
Hematology
Q1
Oncology
Q1
Subject Areas
Aims & Scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research.
The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews.
With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 138 |
| Total Docs. (3 years) | 325 |
| Total Refs. | 11,678 |
| Total Citations (3 years) | 3,240 |
| Citable Docs. (3 years) | 210 |
| Citations / Doc. (2 years) | 10.49 |
| Ref. / Doc. | 84.62 |
| % Female | 43.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.